This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration. This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration.

Etoposide

PubChem CID: 36462

Connections displayed (default: 10).
Loading graph...

ℹ️ Click here to know more about the properties
Compound Synonyms etoposide, VePesid, 33419-42-0, Toposar, trans-Etoposide, (-)-Etoposide, Lastet, Zuyeyidal, Etoposido, Etoposidum, Etoposidum [INN-Latin], VP-16, Etoposide (VP16), VP 16 (pharmaceutical), Sintopozid, Vepesid J, VP-16-213, VP 16-213, Etoposido [INN-Spanish], 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside, NK 171, CCRIS 2392, NSC-141540, DTXSID5023035, HSDB 6517, UNII-6PLQ3CP4P3, EINECS 251-509-1, 6PLQ3CP4P3, 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside), EPEG, CHEBI:4911, Epipodophyllotoxin VP-16213, Etoposide (VP-16), VP 16, 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin, CHEMBL44657, Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside), Epipodophyllotoxin-beta-D-ethyliden-glucoside, 4'-demethyl-, Eposide, DTXCID601473876, Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside, 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside), NSC 141540, Etoposide [USAN:USP:INN:BAN:JAN], Etosid, ETOPOSIDE (IARC), ETOPOSIDE [IARC], Etoposidum (INN-Latin), Etoposido (INN-Spanish), MFCD00869325, ETOPOSIDE (MART.), ETOPOSIDE [MART.], ETOPOSIDE (USP-RS), ETOPOSIDE [USP-RS], (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one, (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside, Etopophos (phosphate salt), ETOPOSIDE (EP IMPURITY), ETOPOSIDE [EP IMPURITY], ETOPOSIDE (EP MONOGRAPH), ETOPOSIDE (USP IMPURITY), ETOPOSIDE [EP MONOGRAPH], ETOPOSIDE [USP IMPURITY], ETOPOSIDE (USP MONOGRAPH), ETOPOSIDE [USP MONOGRAPH], Etopol, Prestwick 211, Demethylepipodophyllotoxin-beta-D-ethylideneglucoside, VP 16213, NSC141540, Etoposide (USAN:USP:INN:BAN:JAN), (10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2,7-trien-12-one, 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one, SMR000112002, VePESID (TN), 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside, Demethyl Epipodophyllotoxin Ethylidine Glucoside, Etoposide,(S), NCGC00016821-01, (5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one, (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol -5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside, EVP, Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-.beta.-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-, CAS-33419-42-0, Etoposide (Standard), Etoposide, VP-16, CPD000112002, ETOPOSIDE [INN], ETOPOSIDE [JAN], ETOPOSIDE [MI], ETOPOSIDE [HSDB], ETOPOSIDE [USAN], Prestwick3_000396, ETOPOSIDE [VANDF], 4'-Demethylepipodophyllotoxin ethylidene-beta-D-glucoside, ETOPOSIDE [WHO-DD], ETOPOSIDE [WHO-IP], SCHEMBL4259, BSPBio_000611, 9-((4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-, 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,4-dimethyloxyphenyl)furo (3',4'':6,7) naptho-(2,3-d)-1,3-dioxol-6 (5aH)-one, MLS000049957, MLS001074951, MLS001424283, MLS002153463, MLS002207239, MLS002222184, Etoposide - Bio-X trade mark, Etoposide (JP18/USP/INN), BPBio1_000673, GTPL6815, ETOPOSIDE [ORANGE BOOK], L01CB01, ETOPOSIDUM [WHO-IP LATIN], HMS2052N05, HMS2089F14, HMS2096O13, HMS2232L03, HMS3713O13, EPE, EX-A1207, Tox21_110630, Tox21_302201, BDBM50127140, HY-13629R, s1225, Etoposide - CAS 33419-42-0, AKOS007930275, BCP9000669, CCG-101165, CS-1774, DB00773, Etoposide, synthetic, >=98%, powder, ME09941, NC00415, SDCCGSBI-0050405.P002, 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside, NCGC00179504-02, NCGC00255126-01, AS-35312, BE164434, Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-(1R)-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-, Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one-, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-, HY-13629, ETOPOSIDE IMPURITY C (EP IMPURITY), SBI-0051910.P002, AB00438905, NS00009585, EN300-97099, C01576, D00125, AB00438905-17, AB00438905-18, AB00438905_19, Q418817, SR-01000763196, SR-01000763196-3, BRD-K37798499-001-02-5, BRD-K37798499-001-05-8, BRD-K37798499-001-10-8, BRD-K37798499-001-14-0, BRD-K37798499-001-18-1, BRD-K37798499-001-21-5, BRD-K37798499-001-22-3, BRD-K37798499-001-25-6, BRD-K37798499-001-27-2, -5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside, Etoposide, British Pharmacopoeia (BP) Reference Standard, Z1304065033, Etoposide, European Pharmacopoeia (EP) Reference Standard, Etoposide, United States Pharmacopeia (USP) Reference Standard, 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-?-D-glucopyranoside), 4?-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-b-D-glucopyranoside), 4''-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside), 4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-(R)-ETHYLIDENE-.BETA.-D-GLUCOPYRANOSIDE), Etoposide for system suitability, European Pharmacopoeia (EP) Reference Standard, (5R,5AR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahy, (5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one, (5R,5AR,8AR,9S)-9-((4,6-O-((1R)-ETHANE-1,1-DIYL)-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-5-(4-HYDROXY-3,5-DIMETHOXYPHENYL)-5,8,8A,9-TETRAHYDRO(2)BENZOFURO(5,6-F)(1,3)BENZODIOXOL-6(5AH)-ONE, (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,3]benzodioxol-8-one, (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3'',4'':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside, 121471-01-0, 251-509-1, 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3'',4'''':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one, FURO(3',4':6,7)NAPHTHO(2,3-D)-1,3-DIOXOL-6(5AH)-ONE-, 9-((4,6-O-ETHYLIDENE-.BETA.-D-GLUCOPYRANOSYL)OXY)5,8,8A,9-TETRAHYDRO-5-(4-HYDROXY-3,5-DIMETHOXYPHENYL), (5R-(5.ALPHA.,5A.BETA.,8A.ALPHA.,9.BETA.(R*)))-
Topological Polar Surface Area 161.0
Hydrogen Bond Donor Count 3.0
Heavy Atom Count 42.0
Isotope Atom Count 0.0
Molecular Complexity 969.0
Database Name cmaup_ingredients;hmdb_chem_all;npass_chem_all;pubchem
Defined Atom Stereocenter Count 10.0
Uniprot Id P08684, P05181, P20815, P05177, P10632, Q92887, P33527, O95255, O15438, P08183, Q9UNQ0, P11388, P02768, Q02880, n.a., Q7ZJM1, Q862F3, P11387, P21447, P06795, P15348, P03118, O15245, P42574, Q01320, Q16236, P03230, P83916, Q9UNA4, P22309, P12530, Q64511, Q9Y6Q9, P06492, Q15788, Q96QA9, Q5T3U5, O75496, P43220, O94956, Q9NPD5, Q9Y6L6, O42275, P81908, Q9NUW8, Q13547, O95342, O15439, P0DTD1
Iupac Name (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
Prediction Hob 0.0
Class Tetrahydroisoquinolines
Target Id NPT1044, NPT979, NPT6327, NPT6574, NPT668, NPT612, NPT72, NPT322
Xlogp 0.6
Superclass Organoheterocyclic compounds
Molecular Formula C29H32O13
Prediction Swissadme 0.0
Inchi Key VJJPUSNTGOMMGY-MRVIYFEKSA-N
Fcsp3 0.5517241379310345
Logs -3.573
Rotatable Bond Count 5.0
State Solid
Logd 1.793
Synonyms (-)-Etoposide, 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside), 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside, 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one, Eposin, Etopophos, Etoposido, Etoposidum, Lastet, Toposar, trans-Etoposide, Vepesid, VP-16, 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-b-D-glucopyranoside), 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-β-D-glucopyranoside), 4-Demethylepipodophyllotoxin b-D-ethylideneglucoside, 4-Demethylepipodophyllotoxin β-D-ethylideneglucoside, 9-((4,6-O-Ethylidine-b-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one, 9-((4,6-O-Ethylidine-β-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one, Baxter oncology brand OF etoposide, Bristol myers brand OF etoposide, Bristol-myers squibb brand OF etoposide, Demethyl epipodophyllotoxin ethylidine glucoside, Etomedac, Etoposide teva, Exitop, Pierre fabre brand OF etoposide, Bristol myers squibb brand OF etoposide, Bristol-myers brand OF etoposide, Celltop, Etoposide pierre fabre, Etoposide, (5a alpha)-isomer, Etoposide, (5a alpha,9 alpha)-isomer, Etoposide, alpha-D-glucopyranosyl isomer, Ferrer brand OF etoposide, Lemery brand OF etoposide, Onkoworks brand OF etoposide, Sanfer brand OF etoposide, Vépéside sandoz, Ribosepharm brand OF etoposide, Baxter brand OF etoposide, Eposide, Eto gry, Eto-gry, Etoposide, (5S)-isomer, Etoposido ferrer farma, Gry brand OF etoposide, Novartis brand OF etoposide, Onkoposid, Pharmachemie brand OF etoposide, Riboposid, Tedec meiji brand OF etoposide, Etopos, Etoposide, alpha D glucopyranosyl isomer, Medac brand OF etoposide, Prasfarma brand OF etoposide, Teva brand OF etoposide, VP 16, Vépéside-sandoz, alpha-D-Glucopyranosyl isomer etoposide, Teva, etoposide
Compound Name Etoposide
Kingdom Organic compounds
Prediction Hob Swissadme 0.0
Exact Mass 588.184
Formal Charge 0.0
Monoisotopic Mass 588.184
Hydrogen Bond Acceptor Count 13.0
Molecular Weight 588.6
Covalent Unit Count 1.0
Total Atom Stereocenter Count 10.0
Total Bond Stereocenter Count 0.0
Molecular Framework Aromatic heteropolycyclic compounds
Esol -3.748512971428574
Inchi InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1
Smiles C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
Nring 7.0
Defined Bond Stereocenter Count 0.0
Taxonomy Direct Parent Tetrahydroisoquinolines

Back to Browse   Back to Home